BGSRX
Price
$99.10
Change
+$1.12 (+1.14%)
Updated
Jun 2 closing price
Net Assets
8.9B
SLMCX
Price
$248.61
Change
+$8.80 (+3.67%)
Updated
Jun 2 closing price
Net Assets
28.72B
Interact to see
Advertisement

BGSRX vs SLMCX

Header iconBGSRX vs SLMCX Comparison
Open Charts BGSRX vs SLMCXBanner chart's image
BGSRX vs SLMCX Comparison Chart in %
View a ticker or compare two or three
VS
BGSRX vs. SLMCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGSRX is a Buy and SLMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SLMCX has more cash in the bank: 28.7B vs. BGSRX (8.9B). BGSRX pays higher dividends than SLMCX: BGSRX (0.89) vs SLMCX (0.00). BGSRX was incepted earlier than SLMCX: BGSRX (18 years) vs SLMCX (43 years). BGSRX (1.53) is less costly to investors than SLMCX (1.16). BGSRX is a more actively managed with annual turnover of: 52.00 vs. SLMCX (33.00). BGSRX has a lower initial minimum investment than SLMCX: BGSRX (100) vs SLMCX (2000). SLMCX annual gain was more profitable for investors over the last year : 103.94 vs. BGSRX (49.15). SLMCX return over 5 years is better than : 97.78 vs. BGSRX (68.88).
BGSRXSLMCXBGSRX / SLMCX
Total Expense Ratio1.421.16122%
Annual Report Gross Expense Ratio1.531.16132%
Fund Existence18 years43 years-
Gain YTD42.22753.03880%
Front LoadN/A6%-
Min. Initial Investment10020005%
Min. Initial Investment IRAN/AN/A-
Net Assets8.9B28.7B31%
Annual Yield % from dividends0.890.00-
Returns for 1 year49.15103.9447%
Returns for 3 years123.29137.0190%
Returns for 5 years68.8897.7870%
Returns for 10 years520.68327.62159%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCAUX12.74N/A
N/A
Invesco Income Advantage U.S. Fund A
FZALX34.40N/A
N/A
Fidelity Advisor Mega Cap Stock Z
FBTTX34.69N/A
N/A
Fidelity Advisor Biotechnology M
MRIGX32.30N/A
N/A
Meridian Growth Investor
FAPKX13.94N/A
N/A
Fidelity Advisor Healthy Future C